IL-2 is a major growth factor for all T-cell subsets acting via a specific membrane receptor. To investigate its role in the pathogenesis of cutaneous T-cell lymphomas (CTCLs), we analysed the expression of high-affinity IL-2 receptors (IL-2Rs) on proliferating cells in these disorders. We showed by immunohistochemical double staining that most cycling cells do not express high-affinity IL-2Rs. Four T-cell lines were established from patients with CTCLs. Two lines required both IL-2 and IL-4 for growth, one line required IL-2 and one line IL-4 alone. The last of these lacked expression of the IL-2R alpha-chain. Thus, IL-2 may not be the only, or the most important, growth stimulus in CTCLs and reactive skin infiltrates. T helper cells, whic...
PURPOSE In leukemic cutaneous T-cell lymphoma (L-CTCL), malignant T cells accumulate in the blood...
Indolent, primary cutaneous T-cell lymphomas (CTCL) are characterized by hyper-proliferation of mali...
Cutaneous T-cell lymphoma (CTCL) is a neoplasm of CD4+ T cells that includes mycosis fungoides and i...
Skin lesions in mycosis fungoides (MF) and cutaneous-type adult T-cell leukemia/lymphoma (c-ATL) are...
Chemokine receptors expressed by normal and neoplastic lymphocytes provide an important mechanism fo...
We have previously demonstrated that peripheral blood mononuclear cells from patients with Sézary sy...
In patients with cutaneous T-cell lymphomas (CTCL), soluble interleukin-2 receptor serum levels (sIL...
In patients with cutaneous T-cell lymphomas (CTCL), soluble interleukin-2 receptor serum levels (sIL...
In patients with cutaneous T-cell lymphomas (CTCL), soluble interleukin-2 receptor serum levels (sIL...
Binding of interleukin-2 (IL-2) to high affinity receptors on activated normal T cells was shown to ...
Binding of interleukin-2 (IL-2) to high affinity receptors on activated normal T cells was shown to ...
In patients with cutaneous T-cell lymphomas (CTCL), soluble interleukin-2 receptor serum levels (sIL...
Studies in an in vitro model of cutaneous T-cell lymphoma (CTCL) demonstrated that CTCL cell prolife...
Group 2 innate lymphoid cells (ILC2s) are distributed systemically and produce type 2 cytokines in r...
Group 2 innate lymphoid cells (ILC2s) are distributed systemically and produce type 2 cytokines in r...
PURPOSE In leukemic cutaneous T-cell lymphoma (L-CTCL), malignant T cells accumulate in the blood...
Indolent, primary cutaneous T-cell lymphomas (CTCL) are characterized by hyper-proliferation of mali...
Cutaneous T-cell lymphoma (CTCL) is a neoplasm of CD4+ T cells that includes mycosis fungoides and i...
Skin lesions in mycosis fungoides (MF) and cutaneous-type adult T-cell leukemia/lymphoma (c-ATL) are...
Chemokine receptors expressed by normal and neoplastic lymphocytes provide an important mechanism fo...
We have previously demonstrated that peripheral blood mononuclear cells from patients with Sézary sy...
In patients with cutaneous T-cell lymphomas (CTCL), soluble interleukin-2 receptor serum levels (sIL...
In patients with cutaneous T-cell lymphomas (CTCL), soluble interleukin-2 receptor serum levels (sIL...
In patients with cutaneous T-cell lymphomas (CTCL), soluble interleukin-2 receptor serum levels (sIL...
Binding of interleukin-2 (IL-2) to high affinity receptors on activated normal T cells was shown to ...
Binding of interleukin-2 (IL-2) to high affinity receptors on activated normal T cells was shown to ...
In patients with cutaneous T-cell lymphomas (CTCL), soluble interleukin-2 receptor serum levels (sIL...
Studies in an in vitro model of cutaneous T-cell lymphoma (CTCL) demonstrated that CTCL cell prolife...
Group 2 innate lymphoid cells (ILC2s) are distributed systemically and produce type 2 cytokines in r...
Group 2 innate lymphoid cells (ILC2s) are distributed systemically and produce type 2 cytokines in r...
PURPOSE In leukemic cutaneous T-cell lymphoma (L-CTCL), malignant T cells accumulate in the blood...
Indolent, primary cutaneous T-cell lymphomas (CTCL) are characterized by hyper-proliferation of mali...
Cutaneous T-cell lymphoma (CTCL) is a neoplasm of CD4+ T cells that includes mycosis fungoides and i...